NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
NeuroPace Inc ( NASDAQ:NPCE ) reported a record revenue of $21.1 million for Q3 2024, marking a 28% increase compared to the same period last year. The company demonstrated disciplined operating expense management, reducing cash burn to $1.8 million for the quarter. NeuroPace Inc ( NASDAQ:NPCE ) increased its cash balance from $55.5 million at the end of Q2 to $56.8 million at the end of Q3, indicating strong financial health. The company successfully expanded its market penetration and utilization of both the RNS system and Dixie Medical products. NeuroPace Inc ( NASDAQ:NPCE ) is on track with its Nautilus study, which could lead to the RNS system being the first device with an FDA-approved indication for idiopathic generalized epilepsy. Gross margin for Q3 2024 was 73.2%, slightly down from 74.5% in the same quarter of 2023. R&D expenses increased to $5.8 million in Q3 2024 from $4.8 million in the same period of 2023, driven by personnel and program expenses. SG&A ex
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]Yahoo! Finance
- Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
- NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.MarketBeat
- NeuroPace Inc.: Q3 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/12/24 - Beat
NPCE
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- NPCE's page on the SEC website